Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma

Kyosuke Nishio(Osaka University of Pharmaceutical Sciences), Kazumasa Komura(Kawasaki Medical School), Takuya Tsujino(Osaka University of Pharmaceutical Sciences), Atsuhiko Yoshizawa(Fujita Health University Hospital), Mamoru Hashimoto(University of Pittsburgh), Fumihiko Urabe(Jikei University School of Medicine), Kensuke Hirosuna(Osaka University of Pharmaceutical Sciences), Takafumi Minami(Kindai University), Ryoichi Maenosono(Osaka University of Pharmaceutical Sciences), Wataru Fukuokaya(Jikei University School of Medicine), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Keiichiro Mori(Jikei University School of Medicine), KAZUKI NISHIMURA(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Taeho Jo(Osaka University), Masanobu Saruta(Fujita Health University), Teruo Inamoto(Hamamatsu University), Kazutoshi Fujita(Kindai University), Takahiro Kimura(Jikei University School of Medicine), Shunsuke Tsuduki(Jikei University School of Medicine), Moritoshi Sakamoto(Osaka University of Pharmaceutical Sciences), Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Hirofumi Morinaka(Kawasaki Medical School), Yutaka Yamamoto(Kindai University), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University)
Anticancer Research
September 26, 2025
Cited by 2


Related Papers